Latest: Watch here for details of new products and services.
- About Us
- Pharmalicensing - Open Innovation for the life sciences
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Due Diligence
- Comparison
- Due Diligence
- Overview
- Top Applications
- Online Panel Discussions
- Request Consultation
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire
- Jobs
- Forums
- Contact Pharmalicensing
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
- Companies
- Browse
Companies
Astex uses a fragment-based approach to discover and develop small molecule molecularly targeted drugs for the treatment of cancer and other human diseases with significant unmet medical need. More
Kalight is devoted to developing patents dealing with viral CNS conditions and seeking licensees and partnerships. Currently, it is marketing its patent for certain herpes neurological conditions. More
Is committed to building on success, and the continued in-licensing of products and technologies is an acknowledged strategic priority More
Replizyme is a service and contract research company specialising in viral enzyme targets and predictive toxicity services to pharmaceutical and biotechnology markets More
BioVex : Developing a new class of vaccines to treat and prevent cancer - OncoVEX and ImmunoVEX, and a functional genomics platform for gene determination in the nervous system - NeuroVEX More
Chiron Corporation is a global pharmaceutical company that develops and commercializes products in the areas of cancer and infectious disease. More
MBRI is a non-profit research institute focused on the discovery and development of pharmaceutical products in the area of cancer, autoimmune diseases and infectious diseases. More
Specialist protease and polymerase drug discovery and development organisation More
Your selection
Browse By
- Industry sector
- Bioinformatics
- Bioinformatics
- Combinatorial biology
- Combinatorial chemistry
- Drug research platforms
- Genomics
- High throughput screening
- Proteomics
- Therapeutic target
- Candida
- Cytomegalovirus
- Ebola virus
- Escherichia coli
- Haemophilus influenzae
- Hantavirus
- Helicobacter pylori
- Herpes simplex virus
- Human B19 parvovirus
- Human papilloma virus
- Parainfluenza virus (Type 3)
- Pertussis
- Respiratory syncytial virus RSV
- Rubella
- Salmonella
- Varicella-zoster
- Geographic location
- Africa
- Asia
- Australia/New Zealand
- Central America
- Europe
- Near & Far East
- North America
- South America
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us